Get startedLog in
    Picture of Redhill Biopharma logo

    RDHL — Redhill Biopharma Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Redhill Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:20-F20-F20-F20-F20-F
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-97.7-71.723.9-8.27-0.429
    Depreciation
    Amortisation
    Non-Cash Items15.726.3-46.1-3.77-7.66
    Discontinued Operations
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-1.158.01-15.62.05-1.97
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Accrued Expenses
    Net Change in Other Assets & Liabilities
    Cash from Operating Activities-65-29.2-35.8-9.37-9.65
    Capital Expenditures-0.115-0.198-0.011-0.009-0.005
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-8.038.50.01501.7
    Sale of Business
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-8.148.30.004-0.0091.69
    Financing Cash Flow Items-7.4-10.98.650.790
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities73.511.521.48.427.32
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash0.179-9.51-14.4-0.952-0.645